Pemigatinib + Pembrolizumab vs Pemigatinib Alone vs Standard of Care for Urothelial Carcinoma (FIGHT-205)
Incyte Corporation
Incyte Corporation
Checkpoint Therapeutics, Inc.
Deciphera Pharmaceuticals, LLC
OHSU Knight Cancer Institute
The Netherlands Cancer Institute
Shanghai Jiao Tong University School of Medicine
G1 Therapeutics, Inc.
Institut Cancerologie de l'Ouest
New Mexico Cancer Research Alliance